Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Mol Pharm. 2016 May 26;13(6):2070–2083. doi: 10.1021/acs.molpharmaceut.6b00205

Figure 4.

Figure 4

Flow cytometry analysis validates high cellular internalization efficiency of LHRH-targeted nanoplatform loaded with DY-547-labeled siRNA after incubation with (A) A2780/CDDP, (B) ES2 and (C) IGROV1 ovarian cancer cells for 24 hours. The values on the right side of the dashed line indicate percentage of cell population transfected with the fluorescent siRNA.